NCT07261332

Brief Summary

To compare the effects of early V/s delayed induction of labour and its outcomes in patients presenting with PROM without labour.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
88

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 10, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 10, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 10, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 20, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 3, 2025

Completed
Last Updated

December 3, 2025

Status Verified

December 1, 2025

Enrollment Period

5 months

First QC Date

November 20, 2025

Last Update Submit

December 2, 2025

Conditions

Keywords

prelabor rupture of membranescomplicated laborearly Versus delayed labor induction

Outcome Measures

Primary Outcomes (1)

  • Duration of labour

    the duration of labour was assesed after each method of induction when patients presented with PROM

    24 hours

Secondary Outcomes (1)

  • Frequency of Normal Vaginal Delivery

    24 hours

Study Arms (2)

early induction of labour for PROM

EXPERIMENTAL

The patients assigned with this arm when presented with PROM were inducted immidiately for labour and no observation was done for 24 hours for spontaneous induction of labour

Drug: 0.5mg PGE2 gel

Late induction of Labour in PROM

ACTIVE COMPARATOR

The patients assigned with this arm were observed for 24 hours for any spontanous induction of labour and then only proceeded with manual induction.

Drug: 0.5mg PGE2 gel

Interventions

In this interventional group patients presenting with PROM will be immediately induced by 0.5mg PGE2 gel. If bishop score will not improve after 6 hours, then application of PGE2 gel will be repeated (maximum 2 doses)

early induction of labour for PROM

Eligibility Criteria

Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemales
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • singleton pregnancy with cephalic presentation
  • gestational age between 37-41 weeks as calculated by last menstrual period date or early dating ultrasoumd
  • Spontaeous PROM as confirmed by history and sterile speculum examination
  • modified bishop score \<6
  • no detectable uterine contractions on admission
  • clear liqour and duration of PROM \<6 hours at admission

You may not qualify if:

  • meconium stained liqour
  • patients with features of chorioamnionitis (fever , tachycardia, abdominal tendernessor foul smeeling vaginal discharge
  • maternal medical diseaseincluding prompt delivery or C section like severe preeeclampsia, renal or cardiac disease
  • presence of contraindications to labour such as placenta previa , Vasa previa,previous uterine surgery (e.g myomectomy ) that increases the risk of uterine rupture , previous C section
  • history of antepartum hemorrhage
  • Moderate to severe IUGR as diagnosed on ultrasound and doppler studies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hameed Lateef Hospital

Lahore, Punjab Province, 54000, Pakistan

Location

MeSH Terms

Conditions

Fetal Membranes, Premature Rupture

Condition Hierarchy (Ancestors)

Obstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Supervisor

Study Record Dates

First Submitted

November 20, 2025

First Posted

December 3, 2025

Study Start

May 10, 2025

Primary Completion

October 10, 2025

Study Completion

October 10, 2025

Last Updated

December 3, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

The participants have not given the cosent to share their personal data

Locations